Teladoc Health (TDOC) 44th Annual J.P. Morgan Healthcare Conference summary

Company Overview, Strategic Vision, and Priorities

• Maintains a leading global position in virtual care, chronic condition management, and mental health, serving over 100 million people and 12,000 clients in the U.S. and internationally.

• Focused on transforming virtual care through innovation, leveraging proprietary technology platforms like Prism and Pulse to deliver integrated care and actionable data insights.

• Strategic priorities for 2025–2026 include enhancing U.S. Integrated Care, advancing mental health access, expanding global presence, and driving operational excellence.

• Emphasis on product development, expanding preventive and hybrid care models, and entering new markets such as the employee assistance program with Wellbound.

• Achieved ISO 9001 certification for key U.S. processes and streamlined operations to improve productivity and cost savings.

Financial Performance and Business Model Evolution

• Reported $2.5 billion in trailing 12-month revenue and $272 million in Adjusted EBITDA as of Q3 2025.

• Over 50% of virtual care revenues now come from visit-based arrangements, reflecting a shift from subscription models and impacting gross margins.

• Maintains a strong financial position with $726 million in cash, ~1.0x net-debt to TTM AEBITDA, and $170 million free cash flow.

• Operational cost reductions in technology, administration, and share-based compensation help offset margin pressures from the business model shift.

• Diversified product portfolio and durable business model support future growth.

Product and Technology Advancements

• Launched a new 24/7 care offering for 2026, expanding service scope and reducing ER visits by 70%.

• Pulse data platform aggregates device and external data, applying AI for engagement, activation, and clinical insights.

• AI is used extensively for clinical decision support, documentation, intake, and hospital device monitoring.

• New AI-enabled stratification models, connected devices, and in-home labs enhance chronic care management and trigger clinical interventions.

• Expanded hybrid care models to increase access, address staffing challenges, and support international growth.